Table 3 Sub-analysis of risk factor/metabolic changes in subjects who completed the trial.
Variable | n | Average Difference | (95% CI) | p value |
|---|---|---|---|---|
Triglycerides < 1.7 mmol/L | 12 | 0.07 | (−0.20, 0.34) | 0.5711 |
Triglycerides > 1.7 mmol/L | 7 | −0.73 | (−1.25, −0.21) | 0.0141 |
Total Cholesterol < 5.2 mmol/L | 15 | −0.27 | (−0.52, −0.01) | 0.0453 |
Total Cholesterol ≥ 5.2 mmol/L | 5 | −0.01 | (−0.53, 0.50) | 0.9516 |
LDL Cholesterol < 3.4 mmol/L | 18 | −0.14 | (−0.41, 0.13) | 0.2821 |
LDL Cholesterol ≥ 3.4 mmol/L | 2 | 0.02 | (−0.23, 0.27) | 0.5 |
HDL Cholesterol ≥ 1 mmol/L | 17 | 0.06 | (−0.034, 0.16) | 0.1796 |
HDL Cholesterol < 1 mmol/L | 2 | 0.09 | (−0.04, 0.22) | 0.07 |
HbA1C < 42 mmol/L | 8 | −4.12 | (−12.74, 4.50) | 0.2958 |
HbA1C ≥ 42 mmol/L | 6 | −4.67 | (−9.00, −0.33) | 0.0395 |
BMI < 30 | 16 | −1.05 | (−1.73, −0.73) | 0.005 |
BMI ≥ 30 | 13 | −1.47 | (−2.53, −0,41) | 0.0105 |
Abdominal circ. ≥ 102 cm | 21 | −5.07 | (−8.15, −0.98) | 0.0026 |
Abdominal circ. < 102 cm | 8 | −3.28 | (−6.20, −035) | 0.0328 |
Systolic BP ≥ 130 mmHg | 24 | −16.04 | (−23.26, −8.82) | 0.0001 |
Systolic BP < 130 mmHg | 9 | −0.78 | (−14.09, 12.53) | 0.89 |
Diastolic BP ≥ 85 mmHg | 11 | −9.55 | (−17.86, −1.23) | 0.0028 |
Diastolic BP < 85 mmHg | 18 | −1.39 | (−5.56, −2.79) | 0.49 |
